Two Sigma Advisers’s Repare Therapeutics RPTX Stock Holding History

Two Sigma Advisers’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,200	Closed	-$141K	–	1725
2025 Q4	$141K	Buy	54,200 +26,500	+96%	+$53.4K	﹤0.01%	2173
2025 Q3	$48.8K	Hold	27,700	–	–	﹤0.01%	2272
2025 Q2	$38.5K	Buy	+27,700	New	+$36.1K	﹤0.01%	2270
2024 Q4	–	Sell	-22,500	Closed	-$77.4K	–	2496
2024 Q3	$77.4K	Sell	22,500 -7,000	-24%	-$23K	﹤0.01%	2186
2024 Q2	$97.3K	Buy	29,500 +17,800	+152%	+$63.5K	﹤0.01%	2325
2024 Q1	$55.1K	Buy	+11,700	New	+$75K	﹤0.01%	2347

Two Sigma Advisers's RPTX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 54,200 shares — an estimated $141K sold.

Two Sigma Advisers first reported a position in RPTX in Q1 2024 and held it in 6 quarters. The position peaked at $141K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Two Sigma Advisers reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 54,200 Repare Therapeutics shares in Q1 2026, an estimated $141K.
Two Sigma Advisers first reported a position in Repare Therapeutics in Q1 2024 and held it in 6 quarters.
Two Sigma Advisers's Repare Therapeutics position peaked at $141K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.